Home  ›  Switzerland  ›  Novartis AG

Novartis AG insider transactions

Healthcare · SIX · Switzerland
Net insider signal · last quarter
Selling
Share price & insider trades · last quarter▲ buy   ▼ sell
CHF 130.6CHF 106.610 Apr09 Jul

Insiders were sellers over the last quarter — 1 sale, no buys — a net CHF 611K of selling. Most recent filing: 18 May 2026.

Net insider flow · last quarter
-CHF 611K0 buys · 1 sells
Insider profiles
+●.●% avg 3m · win rate

Transactions

DateInsiderRoleTypeValue
18 May 2026ManagementSellCHF 611,021
06 Feb 2026ManagementSellCHF 9,551,906
06 Feb 2026ManagementSellCHF 3,595,685
05 Feb 2026Management▼ SellCHF 7,865,330
05 Feb 2026Management▼ SellCHF 2,505,996
28 Jan 2026Management▲ BuyCHF 355,390
07 Nov 2025Management▼ SellCHF 2,034,354
30 Oct 2025Management▼ SellCHF 246,319
16 Sep 2025Management▼ SellCHF 252,610
19 Aug 2025Management▼ SellCHF 3,015,378
13 Aug 2025Management▼ SellCHF 190,440
13 Aug 2025Management▼ SellCHF 337,699
16 Jun 2025Management▼ SellCHF 422,701
03 Jun 2025Management▼ SellCHF 13,076,556
30 Apr 2025Management▼ SellCHF 1,973,994
11 Feb 2025Management▼ SellCHF 312,203
07 Feb 2025Management▼ SellCHF 2,500,279
05 Feb 2025Management▼ SellCHF 1,365,687
04 Feb 2025Management▼ SellCHF 1,840,201
30 Jan 2025Management▲ BuyCHF 699,425
30 Jan 2025Management▲ BuyCHF 698,883
Showing older filings · the 3 most recent are subscriber-only
Visit the website →

Under the EU Market Abuse Regulation (MAR), executives and board members (PDMRs) at Swiss-listed companies must disclose dealings in their company's shares to SIX. Insider Transaction Terminal aggregates these filings daily, filters out the noise and gives you the trades that actually matter.